Home › U.S. consumer groups oppose Teva bid for generic drug rival Mylan
 

Keywords :   


U.S. consumer groups oppose Teva bid for generic drug rival Mylan

2015-07-14 21:13:30| Biotech - Topix.net

A proposed merger of the two largest U.S. generic drug makers drew fire on Tuesday from Consumers Union and seven other groups, who asked antitrust enforcers to stop Teva Pharmaceutical Industries Ltd's ( At this point, there is no deal. Mylan has been rebuffing Teva's takeover bids, including one in April for $40 billion.

Tags: groups drug consumer bid

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Hurricane Milton Public Advisory Number 5A
06.10Summary for Hurricane Milton (AT4/AL142024)
06.10Atlantic Tropical Weather Outlook
06.10Eastern North Pacific Tropical Weather Outlook
06.10Glatfelter Develops Biobased Espresso Lid Material
06.10Tropical Storm Milton Potential Storm Surge Flooding Map
06.10Tropical Storm Milton Probabilistic Storm Surge Graphics
06.10Firms urge mayor to rethink congestion charge plan
More »